These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34118102)

  • 21. Current view and outcome of ITI therapy - A change over time?
    Holstein K; Batorova A; Carvalho M; Fijnvandraat K; Holme P; Kavakli K; Lambert T; Rocino A; Jiménez-Yuste V; Astermark J;
    Thromb Res; 2016 Dec; 148():38-44. PubMed ID: 27770665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
    Rivard GE; Rothschild C; Toll T; Achilles K
    Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.
    Oldenburg J; Austin SK; Kessler CM
    Haemophilia; 2014 Sep; 20 Suppl 6():17-26. PubMed ID: 24975701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor.
    Holstein K; Schneppenheim R; Schrum J; Bokemeyer C; Langer F
    Hamostaseologie; 2014; 34 Suppl 1():S5-8. PubMed ID: 25382771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How I manage patients with inherited haemophilia A and B and factor inhibitors.
    Ljung RCR
    Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
    Astermark J; Morado M; Rocino A; van den Berg HM; von Depka M; Gringeri A; Mantovani L; Garrido RP; Schiavoni M; Villar A; Windyga J;
    Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?
    Holstein K; Le Quellec S; Klamroth R; Batorova A; Holme PA; Jiménez-Yuste V; Astermark J
    Haemophilia; 2022 Mar; 28(2):215-222. PubMed ID: 34918839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
    Oldenburg J; Jiménez-Yuste V; Peiró-Jordán R; Aledort LM; Santagostino E
    Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans?
    Callaghan MU; Rajpurkar M; Chitlur M; Warrier I; Lusher J
    Haemophilia; 2011 May; 17(3):483-9. PubMed ID: 21118335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune tolerance induction in patients with haemophilia a and inhibitors: effectiveness and cost analysis in an European Cohort (The ITER Study).
    Rocino A; Cortesi PA; Scalone L; Mantovani LG; Crea R; Gringeri A; ;
    Haemophilia; 2016 Jan; 22(1):96-102. PubMed ID: 26278414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
    Benson G; Auerswald G; Elezović I; Lambert T; Ljung R; Morfini M; Remor E; Salek SZ
    Eur J Haematol; 2012 May; 88(5):371-9. PubMed ID: 22260405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When is enough…enough? Developing consensus of definition of failure of immune tolerance induction in patients with haemophilia and inhibitors.
    Barnes C; Brown SA; Curtin J; Dunkley S
    Haemophilia; 2014 Jul; 20(4):e275-9. PubMed ID: 24948406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune tolerance induction rescue with turoctocog-alfa in a poor risk haemophilia A inhibitor young child: the history of a success.
    Zanon E; Milan M; Pasca S
    Blood Coagul Fibrinolysis; 2018 Jul; 29(5):465-468. PubMed ID: 29652676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New predictive approaches for ITI treatment.
    Minno GD; Santagostino E; Pratt K; Königs C
    Haemophilia; 2014 Sep; 20 Suppl 6():27-43. PubMed ID: 24975702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors.
    Rocino A; Santagostino E; Mancuso ME; Mannucci PM
    Haematologica; 2006 Apr; 91(4):558-61. PubMed ID: 16585022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of current knowledge to the management of bleeding events during immune tolerance induction.
    Di Paola J; Aledort L; Britton H; Carcao M; Grabowski E; Hutter J; Journeycake J; Kempton C; Leissinger C
    Haemophilia; 2006 Nov; 12(6):591-7. PubMed ID: 17083508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.